儿童葡萄糖皮质醇诱导的骨质疏松症:新兴的血管和分子标
Sisir Kumar Barik1,2, Janet L Crane1,3,2
1Division of Endocrinology, Department of Pediatrics.
Current opinion in pediatrics
|May 29, 2025
概括
儿童的葡萄糖皮质激素诱导骨质疏松症 (GIO) 通过增加再吸收和减少形成,损害骨密度. 针对骨血管系统提供了新的治疗策略,以预防终身骨折风险.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 骨生物学 骨生物学 骨生物学
- 血管生物学 血管生物学
背景情况:
- 葡萄糖皮质激素诱导的骨质疏松症 (GIO) 是长期接受葡萄糖皮质激素治疗的儿童的重大风险.
- GIO影响炎症,自身免疫和遗传疾病,影响骨发育.
研究的目的:
- 审查儿童患者中GIO的病理生理学.
- 探索骨生长期间GIO骨血管系统在骨生长中的作用.
- 确定GIO.的新兴治疗目标.
主要方法:
- 文献综述侧重于GIO病理生理学和骨血管系统.
- 对儿科骨中血管性-骨质性合的最近研究的分析.
- 检查参与骨血管生成的信号通路.
主要成果:
- GIO涉及骨吸收增加和骨形成减少,导致骨矿物密度的快速丧失.
- 在生长的骨架中,血管原生-骨质原生合是至关重要的,内皮细胞发挥着积极的作用.
- 像PDGF-BB和NF-κB这样的信号通路是招募骨质原生体和调节骨血管生成的关键.
结论:
- 儿童的GIO令人担忧,因为它对峰值骨质量和终身骨折风险的影响.
- 了解葡萄糖皮质体对骨血管系统的影响,可能会揭示新的治疗点.
- 维护骨健康和减轻骨质毒性影响在成长中的骨是至关重要的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Hormones and Bone Tissue
3.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K
Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438


